Edition:
United States

Bioera SpA (BIE.MI)

BIE.MI on Milan Stock Exchange

0.25EUR
11:35am EDT
Change (% chg)

€0.01 (+3.20%)
Prev Close
€0.24
Open
€0.25
Day's High
€0.25
Day's Low
€0.24
Volume
184,851
Avg. Vol
215,549
52-wk High
€0.29
52-wk Low
€0.18

Latest Key Developments (Source: Significant Developments)

Bioera completes issue of EUR 2.1 mln non-convertible bonds
Friday, 2 Dec 2016 12:15pm EST 

Bioera SpA :Says it completed issue of non-convertible bonds "Bioera SpA - Bond Issue 2016-2021" of total nominal value of 2.1 million euros ($2.24 million).  Full Article

Bioera approves up to EUR 4 million bond issue
Monday, 21 Nov 2016 02:59am EST 

Bioera SpA : Said on Friday Board approved issue of non-convertible bond loan "Bioera SpA - Bond Issue 2016-2021" of maximum value 4 million euros ($4.25 million) with a rate of 6 percent gross per annum . The bond issue to be matured till December 2, 2021 . The securities may be subscribed by qualified investors, at an issue price equal to 100 percent of the nominal value of each bond .The bonds will be secured by a pledge, equal to 110 pct of the nominal value of bond issue, by shares of subsidiary Ki Group SpA.  Full Article

Bioera sells 24.6 pct stake in KI Group
Tuesday, 5 Jul 2016 02:06am EDT 

Bioera SpA : Signs agreement with Idea Team Srl to sell 24.6 percent stake in KI Group SpA for 6.9 million euros ($7.68 million) .Agreement envisages call option for acquisition by Idea Team of its remaining 50.1 percent stake in KI Group.  Full Article

Bioera published court final approval release of Unopiu's arrangement with creditors; to acquire 100 percent of Unopiu
Friday, 24 Apr 2015 02:34am EDT 

Bioera SpA:Published court final approval release of Unopiu's arrangement with creditors.Based on agreement in next few weeks Splendor Investment Holdings Ltd (SIH), a sub-holding company based in London, will acquire 100 percent of Unopiu SpA.Unopiu's turn-around plan will follow the standard luxury goods business model with main focus on made in Italy furniture and design.Bioera owns 50 percent stake in SIH, followed by its partners Yaks and Bramfield with equal stakes of 25 percent.  Full Article

More From Around the Web

BRIEF-Bioera unit invests 550,000 euros in Meditalia

* Says board approves the investment in Meditalia Srl through Bioera Start Up Italia

No consensus analysis data available.